Smith & Nephew (LON: SN.) shares rose more than 5% on Wednesday after the medical technology firm reported a 3.1% underlying revenue increase for the first quarter of 2025, driven by operational improvements and recent product launches.
Group revenue for the period ended 29 March totalled $1.41 billion, up from $1.39 billion in Q1 2024.
Reported growth was 1.6%, reflecting a 150 basis point foreign exchange headwind. The company said it was a “good start to the year,” reinforcing confidence in its full-year outlook.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Chief Executive Officer Deepak Nath credited the company’s “12-Point Plan” for delivering improved performance.
“Key platforms, such as CORI, EVOS, REGENETEN and our Negative Pressure Wound Therapy portfolio all delivered strong double-digit growth,” Nath said, noting continued momentum from innovation and new product launches.
The company revealed that Orthopaedics delivered 3.2% underlying revenue growth, supported by a sustained improvement in U.S. hip and knee implants. Sports Medicine & ENT posted 2.4% underlying growth, with strong demand in established markets partly offset by weakness in China.
Advanced Wound Management grew 3.8%, led by foams and negative pressure wound therapy.
Despite ongoing tariff-related uncertainty, Smith & Nephew reiterated its 2025 guidance. The company continues to expect around 5% underlying revenue growth and a trading profit margin between 19% and 20%.
Headwinds from China remained a factor, but the company believes their impact has “now passed their peak.”
Searching for the Perfect Broker?
Discover our top-recommended brokers for trading and investing in financial markets. Dive in and test their capabilities with complimentary demo accounts today!
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY
